STUDIES ON THE STRUCTURE OF COMPLEMENT-C3 AND THE STABILITY OF C3 DERIVED PHAGOCYTIC LIGANDS C3B/IC3B IN SJL/J AND BALB/C MICE

被引:8
|
作者
LYNCH, DM [1 ]
KAY, PH [1 ]
PAPADIMITRIOU, JM [1 ]
GROUNDS, MD [1 ]
机构
[1] UNIV WESTERN AUSTRALIA,QUEEN ELIZABETH II MED CTR,DEPT PATHOL,NEDLANDS,WA 6009,AUSTRALIA
来源
EUROPEAN JOURNAL OF IMMUNOGENETICS | 1993年 / 20卷 / 01期
关键词
D O I
10.1111/j.1744-313X.1993.tb00090.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Female SJL/J mice are more susceptible to development of experimental autoimmune myositis than most other mouse strains. Since complement has been implicated in the pathogenesis of inflammatory muscle disease in humans, quantitative and qualitative studies of complement C3 were undertaken in SJL/J and BALB/c mice to determine whether complement may influence disease susceptibility in SJL/J mice. In accordance with previous studies, mature male and female BALB/c mice were shown to have similar serum C3 concentrations. However, differences were found between mature male and female SJL/J mice. Male SJL/J mice have significantly higher serum C3 concentrations than SJL/J females and both sexes of BALB/c mice suggesting that serum C3 concentration may be variably influenced by sex in some mouse strains. Qualitatively, SJL/J mice were shown to have a different allotypic form of C3 (C3F) compared to the common electrophoretically slow form (C3S) found in BALB/c mice and most other mouse strains. Furthermore, studies on the decay rate of (3 revealed that C3b/iC3b fragments are converted to C3c/d at a faster rate in sera from female SJL/J mice compared to female BALB/c mice. Because removal and solubility of immune complexes is influenced by complement C3, it is possible that the more rapid decay of the phagocytic ligands C3b/iC3b may account for the increased susceptibility to development of autoimmune disease in female SJL/J mice.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [31] A COMPARATIVE-EVALUATION OF RECEPTOR REACTIVITIES FOR C3B, IC3B, AND C3D ON RAJI LYMPHOBLASTOID-CELLS
    SCHEINER, O
    HAMMANN, KP
    SCHMID, HU
    SCHULZ, T
    ALSENZ, J
    DIERICH, MP
    INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1982, 69 (03): : 231 - 237
  • [32] ROLE OF C3B IN BREAKDOWN OF C3 IN HYPOCOMPLEMENTEMIC MESANGIOCAPILLARY GLOMERULONEPHRITIS
    WILLIAMS, DG
    PETERS, DK
    LACHMANN, PJ
    CHARLESWORTH, JA
    LANCET, 1973, 1 (7801): : 447 - 449
  • [33] EVIDENCE FOR A NEW MECHANISM OF CONTROL OF C3 AND C3B ACTIVITY
    SPITZER, RE
    STITZEL, AE
    URMSON, JR
    RITTENHOUSE, KW
    BOCK, GH
    FEDERATION PROCEEDINGS, 1978, 37 (06) : 1751 - 1751
  • [34] THE CONFORMATIONAL BASIS FOR THE LOSS OF C3B FUNCTIONAL-ACTIVITY FOLLOWING CONVERSION TO IC3B
    ISENMAN, DE
    FEDERATION PROCEEDINGS, 1982, 41 (03) : 375 - 375
  • [35] Deposition of C3b/iC3b leads to the concealment of antigens, immunoglobulins and bound C1q in complement-activating immune complexes
    Nilsson, UR
    MOLECULAR IMMUNOLOGY, 2001, 38 (2-3) : 151 - 160
  • [36] COMPLEMENT RECEPTORS (C3B, C4B-C3D) UNBALANCE ON CLL LYMPHOCYTES
    PERUSSIA, B
    CASALI, P
    JOPPOLO, G
    BORZINI, P
    BOLLETTINO DELL ISTITUTO SIEROTERAPICO MILANESE, 1976, 55 (03): : 235 - 240
  • [37] VALIDATION OF C3, IC3B, C3D, C4D, PROPERDIN C5 AND C5B-9 ASSAYS TO MONITOR COMPLEMENT ACTIVATION IN KIDNEY TRANSPLANT PATIENTS
    Lammerts, Rosa
    Jager, Tina
    Meter, Anita H.
    Seelen, Marc
    van den Born, Jaap
    Berger, Stefan
    Daha, Mohamed
    TRANSPLANT INTERNATIONAL, 2021, 34 : 251 - 251
  • [38] ELISA for evaluating the incorporation of plasma derived complement split-products C3b/iC3b into solid-phase immune complexes
    Zimmermann-Nielsen, E
    Svehag, SE
    Thorlacius-Ussing, O
    Baatrup, G
    JOURNAL OF IMMUNOLOGICAL METHODS, 2001, 249 (1-2) : 43 - 51
  • [39] 2 DIFFERENT COMPLEMENT RECEPTORS ON HUMAN LYMPHOCYTES - ONE SPECIFIC FOR C3B AND ONE SPECIFIC FOR C3B INACTIVATOR-CLEAVED C3B
    ROSS, GD
    POLLEY, MJ
    RABELLINO, EM
    GREY, HM
    JOURNAL OF EXPERIMENTAL MEDICINE, 1973, 138 (04): : 798 - 811
  • [40] Blood concentrations of complement split product iC3b and serum C3 associate with SLE disease activity
    Kim, Alfred
    Strand, Vibeke
    Sen, Deepali
    Fu, Qiang
    Mathis, Nancy
    Schmidt, Martin
    Bruchas, Robin
    Staten, Nick
    Olson, Paul
    Stiening, Chad
    Atkinson, John
    MOLECULAR IMMUNOLOGY, 2018, 102 : 174 - 174